Matches in Wikidata for { <http://www.wikidata.org/entity/Q64151241> ?p ?o ?g. }
Showing items 1 to 54 of
54
with 100 items per page.
- Q64151241 description "clinical trial" @default.
- Q64151241 description "ensayu clínicu" @default.
- Q64151241 description "klinisch onderzoek" @default.
- Q64151241 description "клінічне випробування" @default.
- Q64151241 name "A Study of LY3214996 Administered Alone or in Combination With Other Agents in Participants With Advanced/Metastatic Cancer" @default.
- Q64151241 type Item @default.
- Q64151241 label "A Study of LY3214996 Administered Alone or in Combination With Other Agents in Participants With Advanced/Metastatic Cancer" @default.
- Q64151241 prefLabel "A Study of LY3214996 Administered Alone or in Combination With Other Agents in Participants With Advanced/Metastatic Cancer" @default.
- Q64151241 P1050 Q64151241-AF756E7B-F358-4FE7-A572-B6B9FA2B4D23 @default.
- Q64151241 P1132 Q64151241-1980070D-AA07-4805-9E10-894EF0A9CDB4 @default.
- Q64151241 P1476 Q64151241-4DCA7D8C-E957-47A0-BD51-3B2257C167F3 @default.
- Q64151241 P17 Q64151241-16AADB47-387B-44A8-A45F-E821C3F44456 @default.
- Q64151241 P17 Q64151241-6E3A2E4B-6293-48AF-A568-563AED226BA5 @default.
- Q64151241 P17 Q64151241-C8C6877E-16CB-4956-AED7-48810B6FF6E7 @default.
- Q64151241 P17 Q64151241-E554A0C1-1C56-4D57-9908-B50D8C029805 @default.
- Q64151241 P2899 Q64151241-03C74A97-A14C-48BA-B820-655E5A038BEE @default.
- Q64151241 P3098 Q64151241-7551934A-4FD1-464C-B6CC-59929E724519 @default.
- Q64151241 P31 Q64151241-81ABDC92-282E-42E2-A6F6-165D56182CE3 @default.
- Q64151241 P4844 Q64151241-F89E5613-77EC-40AF-9D3E-D3E989502283 @default.
- Q64151241 P580 Q64151241-C111F7B5-9969-438F-BEFE-C080C03EA998 @default.
- Q64151241 P582 Q64151241-06037237-2ACE-47B8-8336-2D76A7DB688F @default.
- Q64151241 P6099 Q64151241-19051A3E-38C3-4463-BBFA-4BE8297E7DF9 @default.
- Q64151241 P6153 Q64151241-3FA17919-486C-4B72-90BF-935750A7B0F0 @default.
- Q64151241 P6153 Q64151241-82900D2B-7301-4102-B030-82ECE40DECE1 @default.
- Q64151241 P6153 Q64151241-82910BA8-57EA-4017-97E6-8B863BD89D49 @default.
- Q64151241 P6153 Q64151241-884D0939-CBD3-4F56-8E88-22070229B489 @default.
- Q64151241 P6153 Q64151241-92F1BDA2-EEDB-4208-ACD9-918E0A9DAC99 @default.
- Q64151241 P6153 Q64151241-BB619B61-EA3E-420E-9B28-62B04ECDD6F5 @default.
- Q64151241 P6153 Q64151241-D7D126F0-DC06-44D4-884D-4FEB8212E32C @default.
- Q64151241 P6153 Q64151241-EBE393E7-A6FB-430E-9D8D-0C9C61853C78 @default.
- Q64151241 P8363 Q64151241-EFD1528B-26A9-4433-AB52-1BF849767952 @default.
- Q64151241 P1050 Q356033 @default.
- Q64151241 P1132 "+272" @default.
- Q64151241 P1476 "A Phase 1 Study of an ERK1/2 Inhibitor (LY3214996) Administered Alone or in Combination With Other Agents in Advanced Cancer" @default.
- Q64151241 P17 Q142 @default.
- Q64151241 P17 Q17 @default.
- Q64151241 P17 Q30 @default.
- Q64151241 P17 Q408 @default.
- Q64151241 P2899 "+18" @default.
- Q64151241 P3098 "NCT02857270" @default.
- Q64151241 P31 Q30612 @default.
- Q64151241 P4844 Q423762 @default.
- Q64151241 P580 "2016-09-29T00:00:00Z" @default.
- Q64151241 P582 "2021-12-15T00:00:00Z" @default.
- Q64151241 P6099 Q5452194 @default.
- Q64151241 P6153 Q11663219 @default.
- Q64151241 P6153 Q126412 @default.
- Q64151241 P6153 Q1525831 @default.
- Q64151241 P6153 Q1808012 @default.
- Q64151241 P6153 Q266227 @default.
- Q64151241 P6153 Q30270369 @default.
- Q64151241 P6153 Q333886 @default.
- Q64151241 P6153 Q55454195 @default.
- Q64151241 P8363 Q78089383 @default.